Navigation Links
CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Date:6/23/2011

hin the body where they may establish new tumor sites. It also cocoons the tumor cells to protect them from the body's natural signaling mechanisms that would cause deviant tumor cells to be eliminated. In a similar fashion, FAK protects tumors from chemotherapeutic drugs and radiation, allowing the tumor cells to resist these therapies.  

About CureFAKtor Pharmaceuticals

CureFAKtor Pharmaceuticals is a biopharmaceutical company focused on the research and development of Focal Adhesion Kinase therapies to prevent or treat cancer.  The Company has identified more  than 40 compounds that target specific FAK signaling sites.  CureFAKtor's investigational and combination therapy products target pancreatic, breast, colon, melanoma, lung and brain oncology disorders. CureFAKtor research is conducted at the Roswell Park Cancer Institute.  CureFAKtor is planning a Phase I clinical study of CFAK-C4 in combination with gemcitabine chemotherapy, the current standard of care for pancreatic cancer, in 2012.  Additional information about the company may be found at www.curefaktor.com

Forward-Looking Safe Harbor Statement:

This press release contains forward-looking statements for CureFAKtor Pharmaceuticals that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements.  

Media Contact
Rx Communications Group, LLC
Eric Goldman
Vice President, Public Relations
917-322-2563
egoldman@rxir.com


'/>"/>
SOURCE CureFAKtor Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
2. CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer
3. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
4. Radient Pharmaceuticals Corporation Joins OTCQX
5. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
6. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
7. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
9. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
10. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
11. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... 2014  Pacific Medical Data Solutions is excited to ... . The main website, along with the site,s blog, ... services and content relevant to the medical billing industry. ... viewers can now better understand how PMDS products help ... create a more visible platform about medical billing best ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
... Skin Infections, SAN DIEGO, Sept. 22 Trius ... of the oral form of its,second-generation oxazolidinone antibacterial drug ... tolerability of once-daily doses,of 200, 300 and 400 milligrams ... for five to seven days of treatment., The ...
... whose breast cancer has,spread to their lymph nodes, a ... the method for determining whether those,women need radiation therapy ... presented during the annual meeting of the American Society ... Boston., In a retrospective study of 167 patients ...
Cached Medicine Technology:Trius Doses First Patient in Antibacterial Phase 2 Trial 2Breast MRI Scan Could Determine Need for Radiation Therapy 2
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Selling cigarettes ... or illegal tobacco and doesn,t harm sales in small ... problems were predicted by the tobacco industry when it ... in the world to introduce plain packaging for tobacco ... Ireland, New Zealand and the U.K. Researchers surveyed ...
(Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
(Date:8/29/2014)... Barbara, CA (PRWEB) August 29, 2014 ... in Santa Barbara in the Santa Barbara News-Press Readers’ ... Evolutions won the Readers’ Choice poll as Best Medical ... 20, 2014 reads the following about Evolutions Medical Spa ... spa, but it is recognized as a top-notch, cutting-edge ...
(Date:8/29/2014)... COLUMBUS, Ohio (PRWEB) August 29, 2014 ... vice president of operations & business development. , Rees ... the vice president of business development. , A wholly ... (OPRS), Senior Independence provides older adults with options, including ... teams, in-home care (e.g., meal preparation) and therapeutic adult ...
(Date:8/29/2014)... Last week, the Fed reported an increase in ... rose to 0.4% while manufacturing output progressed to 1.0%. ... boost since February this year. Capacity use has increased by ... – an increase that could be attributed to the boost ... which is a measure of slack across the industries. , ...
Breaking Medicine News(10 mins):Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3
... Findings may explain link between breathing in dirty air ... -- Long-term exposure to the air pollution particles caused ... blood pressure, U.S. researchers say. , In the new ... Normative Aging Study, who were assessed every four years ...
... warmer than 75 degrees poses added risks , THURSDAY, March ... deaths in New York City go up with the temperature: ... 75 degrees Fahrenheit. , The findings, published online March ... death statistics in the city from 1990 through 2006. , ...
... ... ... ... ...
... replicate the human brain, or to develop nanotechnology that ... neurons and other types of cellular networks? Once ... other in ways that could propel extraordinary new research. ... an hour-long conversation recently led by neuroscientist Nicholas Spitzer. ...
... , ... ... ... ...
... Henry Ford Hospital study has shown a link between Vitamin ... lead researchers to better understand the development of the most ... researchers at Henry Ford and Wayne State University found elevated ... taken from 10 patients compared to normal skin tissue taken ...
Cached Medicine News:Health News:Years of Exposure to Traffic Pollution Raises Blood Pressure 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 3Health News:Anthera Pharmaceuticals Completes Initial Public Offering 4Health News:Anthera Pharmaceuticals Completes Initial Public Offering 5Health News:Anthera Pharmaceuticals Completes Initial Public Offering 6Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 2Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 3Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 4Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 5Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 6Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 7Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 8Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 9
... scale accommodates standard to extra-wide wheelchairs (18" ... The low-profile, heavy-duty, anodized aluminum weighing platform ... high providing easy access for large patients. ... steel digital readout. The 6772 has the ...
This high-capacity stand-on scale provides extra sensitivity and support to patients who are unsteady on their feet. Advanced technology compensates for patient movement....
... 100 provides a new screening, diagnostic, treatment ... medical management of sleep-related breathing disorders. The ... unmet need for an ambulatory, reliable, patient ... to the great number of OSA sufferers, ...
... synthesized by the parathyroid glands [1,2] ... extracellular calcium concentrations. PTH prevents hypocalcemia ... calcium excretion by the kidney. Following ... is rapidly degraded into 4 fragments: ...
Medicine Products: